Please login to the form below

Not currently logged in
Email:
Password:

Vida

This page shows the latest Vida news and features for those working in and with pharma, biotech and healthcare.

Digital home care platform launched in the UK

Digital home care platform launched in the UK

The service - Vida - uses a digital platform to connect patients with carers, taking level of need, care specialisation, location, culture, gender and interests into account to tailor the matches. ... Currently available in London, the Vida service is

Latest news

  • AstraZeneca forms 'smart inhaler' digital health partnership AstraZeneca forms 'smart inhaler' digital health partnership

    Health coaching mobile app. The Adherium deal is AZ's second digital health collaboration in a week, and follows hot on the heals of its tie-up with Vida on a ... Vida's health coach app, which is generally used by those whose goal is weight-loss,

  • Boehringer launches integrated Hispanic diabetes campaign Boehringer launches integrated Hispanic diabetes campaign

    The collaboration will be part of the network's 'Salud Es Vida' (Health is Life )  health platform, aimed at raising awareness, increasing knowledge and encouraging positive health decision-making among the ... Pharmaceuticals. As part of the

  • Pharma companies announce new appointments

    VIDA Sciences appoints William Harrison. Finally, William M Harrison, chief executive officer of contract research organisation (CRO) consultancy VIDA Sciences, has been appointed to the board of directors of Numira Biosciences,

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...